Effect of selenium supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A review on current evidence
Subject Areas :Raheleh Kamalzadeh Yazdi 1 , Ghazaleh Shakeri 2 , Motahareh Hatami Marbini 3 , Behnood Abbasi 4
1 - Department of Nutrition, Electronic Health and Statistics Surveillance Research Center, Science and Research Branch. Islamic Azad University, Tehran, Iran.
2 - Department of Nutrition, Electronic Health and Statistics Surveillance Research Center, Science and Research Branch. Islamic Azad University, Tehran, Iran.
3 - Department of Nutrition, Electronic Health and Statistics Surveillance Research Center, Science and Research Branch. Islamic Azad University, Tehran, Iran.
4 - Department of Nutrition, Electronic Health and Statistics Surveillance Research Center, Science and Research Branch. Islamic Azad University, Tehran, Iran.
Keywords:
Abstract :
- Global report on diabetes: World Health Organization; 2016 [Available from: http://www.who.int/diabetes/global-report/en/.
- IDF Atlas: International Diabetes Federation; 2015 [Seventh:[Available from: http://www.diabetesatlas.org/.
- Federation ID. IRAN: International Diabetes Federation; 2016 [Available from: https://www.idf.org/our-network/regions-members/middle-east-and-north-africa/members/35-iran.html.
- Stapleton SR. Selenium: an insulin-mimetic. Cellular and Molecular Life Sciences. 2000;57(13-14):1874-9.
- Faghihi T, Radfar M, Barmal M, Amini P, Qorbani M, Abdollahi M, et al. A randomized, placebo-controlled trial of selenium supplementation in patients with type 2 diabetes: effects on glucose homeostasis, oxidative stress, and lipid profile. American Journal of Therapeutics. 2014;21(6):491-5.
- Faure P, Ramon O, Favier A, Halimi S. Selenium supplementation decreases nuclear factor‐kappa B activity in peripheral blood mononuclear cells from type 2 diabetic patients. European Journal of Clinical Investigation. 2004;34(7):475-81.
- Farrokhian A, Bahmani F, Taghizadeh M, Mirhashemi S, Aarabi M, Raygan F, et al. Selenium supplementation affects insulin resistance and serum hs-CRP in patients with type 2 diabetes and coronary heart disease. Hormone and Metabolic Research. 2016;48(04):263-8.
- Jamilian M, Razavi M, Fakhrie Kashan Z, Ghandi Y, Bagherian T, Asemi Z. Metabolic response to selenium supplementation in women with polycystic ovary syndrome: a randomized, double‐blind, placebo‐controlled trial. Clinical Endocrinology. 2015;82(6):885-91.
- Yang S, Hwang S, Choi H, Yoo H, Seo J, Kim S, et al. Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: Implications for insulin resistance, inflammation, and atherosclerosis. The Journal of Clinical Endocrinology & Metabolism. 2011;96(8):E1325-E9.
- Kim JE, Choi SI, Lee HR, Hwang IS, Lee YJ, An BS, et al. Selenium significantly inhibits adipocyte hypertrophy and abdominal fat accumulation in OLETF rats via induction of fatty acid beta-oxidation. Biological Trace Element Research. 2012;150(1-3):360-70.
- He Y-T, Liu D-W, Ding L-Y, Li Q, Xiao Y-H. Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis. World Journal of Gastroenterology. 2004;10(5):703.
- Duntas L. Selenium and inflammation: underlying anti-inflammatory mechanisms. Hormone and Metabolic Research. 2009;41(06):443-7.
- Ozturk IC, Batcioglu K, Karatas F, Hazneci E, Genc M. Comparison of plasma malondialdehyde, glutathione, glutathione peroxidase, hydroxyproline and selenium levels in patients with vitiligo and healthy controls. Indian Journal of Dermatology. 2008;53(3):106.
- Rohr‐Udilova N, Sieghart W, Eferl R, Stoiber D, Björkhem‐Bergman L, Eriksson LC, et al. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma. Hepatology. 2012;55(4):1112-21.
- Zeng J, Zhou J, Huang K. Effect of selenium on pancreatic proinflammatory cytokines in streptozotocin-induced diabetic mice. The Journal of Nutritional Biochemistry. 2009;20(7):530-6.